According to American Diabetes Association guidelines, this risk increases when tirzepatide is combined with insulin or sulfonylureas
Southern European countries, including Italy and Spain, amplify demand as public systems widen obesity coverage
"Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist." Cell metabolism 34.1 (2022): 59-74
This was part of research on the digestive system
People with obesity are at a higher risk of developing life-threatening cancer, and 2.1 million new cases are expected this year, according to the American Cancer Society
The deeper story, supported by emerging research, is that NAD+ may be upstream of GLP-1 production entirely